Key result
Breast radiotherapy with deep inspiration breath-hold limits maximum pacemaker dose below 2.0 Gy without malfunction.
Why the study?
Radiation therapy planning is complex in pacemaker-dependent breast cancer patients, as device radiation exposure can lead to malfunction with serious clinical consequences.
Can adjuvant breast radiotherapy be delivered safely without device malfunction in pacemaker-dependent patients using 6 MV photon beams and DIBH techniques?
Observational (n=5)
No
Can adjuvant breast radiotherapy be delivered safely without device malfunction in pacemaker-dependent patients using 6 MV photon beams and DIBH techniques?
Adjuvant breast radiotherapy can be safely delivered to pacemaker-dependent patients using low-energy photon beams, DIBH, and meticulous dosimetric planning without compromising device functionality.
Answers are grounded in this paper and cite their sources.
Supports feasibility of safe adjuvant RT in pacemaker-dependent patients; leaves open need for larger prospective validation.
Introduction: Radiation therapy (RT) is a standard component of breast cancer management; however, treatment planning becomes more complex in patients with cardiac implantable electronic devices (CIEDs), including pacemakers (PMs) and implantable cardioverter-defibrillators (ICDs). Exposure of these devices to therapeutic radiation may lead to malfunction, particularly in pacemaker-dependent individuals, where device failure can have serious clinical consequences. Careful treatment planning is therefore essential when irradiating breast cancer patients with implanted cardiac devices. This report presents our institutional experience in the safe administration of adjuvant RT in a pacemaker-dependent patient undergoing treatment for breast cancer. Materials and Methods: A retrospective review was conducted of five breast cancer patients with dual-chamber pacemakers, all of whom were pacemaker-dependent, treated with adjuvant external beam radiation therapy between January 2023 and December 2024, Simulation imaging was performed using both free-breathing and deep inspiration breath-hold (DIBH) computed tomography (CT) protocols. Target volumes and organs at risk were delineated according to ESTRO/RTOG contouring guidelines, with the pacemaker generator and leads contoured separately as organs at risk. Treatment planning was performed using 6 MV photon beams with field-in-field and hybrid intensity-modulated radiation therapy (IMRT) techniques. Volumetric modulated arc therapy (VMAT) plans were additionally generated for dosimetric comparison. Pacemaker dose constraints were established in accordance with the recommendations of the American Association of Physicists in Medicine Task Group 203 (AAPM TG-203). Prior to treatment initiation, multidisciplinary evaluation was undertaken, including cardiology consultation, device interrogation before and after treatment, and preparation of emergency pacing support protocols. Results: Adjuvant RT was completed successfully without interruption. Target coverage was clinically acceptable, with 96.8% of the planning target volume (PTV) receiving at least 95% of the prescribed dose (PTV V95% = 96.8%). Use of DIBH contributed to cardiac sparing, resulting in a mean heart dose of 1.9 Gy and a mean dose to the left anterior descending artery (LAD) of 4.1 Gy. The maximum recorded dose to the pacemaker was 0.86 Gy, remaining well below established safety thresholds. No pacemaker malfunction, sensing abnormalities, or cardiac complications were observed during treatment. Acute toxicity was limited to grade 1 radiation dermatitis. Conclusion: Adjuvant breast radiotherapy in pacemaker-dependent patients can be delivered safely with appropriate precautions. The use of low-energy photon beams, DIBH techniques, meticulous dosimetric planning, and multidisciplinary coordination enables effective target coverage while maintaining pacemaker dose within acceptable limits, without compromising oncologic outcomes or device functionality.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2026) conducted an observational in Breast cancer in pacemaker-dependent patients (n=5). Adjuvant external beam radiation therapy with DIBH was evaluated on Target coverage (PTV V95%). Adjuvant breast radiotherapy using deep inspiration breath-hold in pacemaker-dependent patients achieved excellent target coverage while keeping the maximum pacemaker dose below 2.0 Gy without device malfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: